Search research articles
Contact Us
Filters
Showing results (31-40 of 120) with videos related to
Page
of 12
Sort By:
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
October 2, 2007
Letter: comments for consideration by the facial lipoatrophy panel
Angelica Kavouni, Lada Lysakova, Sharon Brown, et al.
HIV Medicine
|
July 14, 2021
The benefits of tenofovir discontinuation with or without bisphosphonate therapy in osteoporotic people living with HIV
Jonathan Jin Hei Lei, Branca Pereira, Graeme Moyle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 19, 2008
The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen
Laura Waters, Sundhiya Mandalia, Paul Randell, et al.
Clinical Therapeutics
|
January 4, 2012
The effect of a 12-week course of omega-3 polyunsaturated fatty acids on lipid parameters in hypertriglyceridemic adult HIV-infected patients undergoing HAART: a randomized, placebo-controlled pilot trial
Barry S Peters, Anthony S Wierzbicki, Graeme Moyle, et al.
Journal of the International AIDS Society
|
November 14, 2014
Impact of NRTI backbone on renal, bone and cardiovascular markers in HIV-infected individuals receiving a boosted protease inhibitor
Tristan Barber, Andrew Hill, Gurmit Jagjit Singh, et al.
Antiviral Therapy
|
March 26, 2004
Enhanced T-cell maturation, differentiation and function in HIV-1-infected individuals after growth hormone and highly active antiretroviral therapy
Antonio Pires, Jeffrey Pido-Lopez, Graeme Moyle, et al.
AIDS (London, England)
|
August 4, 2011
T-cell signalling in antiretroviral-treated, aviraemic HIV-1-positive individuals is present in a raised state of basal activation that contributes to T-cell hyporesponsiveness
Jocelyn S Downey, Meriem Attaf, Graeme Moyle, et al.
Molecular Medicine (Cambridge, Mass.)
|
August 10, 2012
CCR5 antagonism impacts vaccination response and immune profile in HIV-1 infection
Samantha J Westrop, Graeme Moyle, Akil Jackson, et al.
Journal of Medical Virology
|
February 26, 2008
Overcoming resistance to existing therapies in HIV-infected patients: the role of new antiretroviral drugs
Carlo-Federico Perno, Graeme Moyle, Chris Tsoukas, et al.
AIDS Patient Care and Stds
|
May 16, 2008
Potential for new antiretrovirals to address unmet needs in the management of HIV-1 infection
Graeme Moyle, Jose Gatell, Carlo-Federico Perno, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 120) with videos related to
Sort By:
Page
of 12
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
October 2, 2007
Letter: comments for consideration by the facial lipoatrophy panel
Angelica Kavouni, Lada Lysakova, Sharon Brown, et al.
HIV Medicine
|
July 14, 2021
The benefits of tenofovir discontinuation with or without bisphosphonate therapy in osteoporotic people living with HIV
Jonathan Jin Hei Lei, Branca Pereira, Graeme Moyle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 19, 2008
The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen
Laura Waters, Sundhiya Mandalia, Paul Randell, et al.
Clinical Therapeutics
|
January 4, 2012
The effect of a 12-week course of omega-3 polyunsaturated fatty acids on lipid parameters in hypertriglyceridemic adult HIV-infected patients undergoing HAART: a randomized, placebo-controlled pilot trial
Barry S Peters, Anthony S Wierzbicki, Graeme Moyle, et al.
Journal of the International AIDS Society
|
November 14, 2014
Impact of NRTI backbone on renal, bone and cardiovascular markers in HIV-infected individuals receiving a boosted protease inhibitor
Tristan Barber, Andrew Hill, Gurmit Jagjit Singh, et al.
Antiviral Therapy
|
March 26, 2004
Enhanced T-cell maturation, differentiation and function in HIV-1-infected individuals after growth hormone and highly active antiretroviral therapy
Antonio Pires, Jeffrey Pido-Lopez, Graeme Moyle, et al.
AIDS (London, England)
|
August 4, 2011
T-cell signalling in antiretroviral-treated, aviraemic HIV-1-positive individuals is present in a raised state of basal activation that contributes to T-cell hyporesponsiveness
Jocelyn S Downey, Meriem Attaf, Graeme Moyle, et al.
Molecular Medicine (Cambridge, Mass.)
|
August 10, 2012
CCR5 antagonism impacts vaccination response and immune profile in HIV-1 infection
Samantha J Westrop, Graeme Moyle, Akil Jackson, et al.
Journal of Medical Virology
|
February 26, 2008
Overcoming resistance to existing therapies in HIV-infected patients: the role of new antiretroviral drugs
Carlo-Federico Perno, Graeme Moyle, Chris Tsoukas, et al.
AIDS Patient Care and Stds
|
May 16, 2008
Potential for new antiretrovirals to address unmet needs in the management of HIV-1 infection
Graeme Moyle, Jose Gatell, Carlo-Federico Perno, et al.
Page
of 12